Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of PET/CT Versus Diagnostic CT for the Detection of Clear Cell Renal Cell Carcinoma in Pre-surgical Patients With Renal Masses Using Iodine-124 Labeled Chimeric G250 (124I-cG250)

NCT00606632 is registered in ClinicalTrials.gov with Heidelberg Pharma AG as lead sponsor.

NCT NCT00606632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00606632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of PET/CT Versus Diagnostic CT for the Detection of Clear Cell Renal Cell Carcinoma in Pre-surgical Patients With Renal Masses Using Iodine-124 Labeled Chimeric G250 (124I-cG250)
Lead sponsor
Heidelberg Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2009
Enrollment
226 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, renal cell carcinoma